COVID-19. Covid-19 infection
Conditions
Interventions
Intervention 1: Control group: There are patients who receive standard treatment for COVID-19 (oseltamivir, hydroxychloroquine and lopinavir) according to the protocol of the Ministry of Health. Inter
Sponsors
Ahvaz University of Medical Sciences
Paya Fan Yakht Alborz Company
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Definitive confirmation of Covid 19 based on PCR results and approved global health clinical signs confirmed by a specialist; They are hospitalized. Patients have informed consent to enter the study.
Exclusion criteria
Exclusion criteria: The physician's decision not to participate in the study. The patient to be present in another clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fever. Timepoint: Daily monitoring from the beginning of the intervention to the end. Method of measurement: Thermometer.;Oxygen saturation. Timepoint: Daily monitoring from the beginning of the intervention to the end. Method of measurement: Pulse oximeter.;Dry cough. Timepoint: Daily monitoring from the beginning of the intervention to the end. Method of measurement: Physical examination,questionnaire.;C-reactive protein (CRP). Timepoint: The first day and the 7th day. Method of measurement: Blood sampling- ELISA.;Interleukin 6 (IL-6). Timepoint: The first day and the 7th day. Method of measurement: Blood Sample method: ELISA ; sensivity 0.06 pg/ml. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of Stay in ICU. Timepoint: Since the first day till end of stay in ICU. Method of measurement: Observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Shahab Atashi
Hakhamanesh Biotechnology
Outcome results
None listed